News

New Cleveland Clinic research reveals vaccinated staff had higher flu infection rates, but experts caution about study ...
Traditional vaccines are made by attenuating Bacillus anthracis or culturing non-pathogenic Bacillus anthracis, which may ...
It reported revenues of 38.41 million yuan in the first half of 2024 and a net loss of 903 million yuan, hit by falling ...
The investigational mRNA-1010 influenza vaccine has undergone extensive clinical evaluation in a series of trials involving ...
The vaccine – now dubbed Vidprevtyn – is based on a recombinant protein antigen developed by Sanofi's vaccines unit Sanofi Pasteur, and also includes an immune-boosting adjuvant developed by ...
The journal 'Nature' publishes data from Wales showing a 20% reduction in risk with vaccination. They support the hypothesis ...
You're not likely to hear it brought up in casual conversation, but recombinant DNA has changed the world in a relatively ...
Recombinant proteins are important components for a wide range of applications, from therapeutic antibodies and vaccines to diagnostics and enzymes. Microbiosci is committed to advancing the science ...
Founded in 1987 in the US, Gale Smith – VP of vaccine development at Novavax – invented the technique of using insect cells for producing recombinant protein vaccines. A further milestone came ...
The global vaccine CDMO market is set to witness a growth rate of 8% in the next 5 years. Increasing demand for vaccines, ...
Newseria nie ponosi odpowiedzialności za treści oraz inne materiały (np. infografiki, zdjęcia) przekazywane w „Biurze Prasowym”, których autorami są zarejestrowani użytkownicy tacy jak agencje PR, ...